Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Election 2020: Industry Loses Three Favored Incumbents In Battle For Senate Control

Republicans Cory Gardner (CO), Martha McSally (AZ) defeated, Alabama Dem Doug Jones goes down as the ballot counting continues

Executive Summary

A few of the US Senate candidates favored and given tens of thousands of dollars by industry have lost their battles for re-election.

You may also be interested in...



Next Year’s Congress Likely To Reinforce ACA Preexisting Conditions, Attorneys Say

Industry attorneys predict that in the absence of the Supreme Court’s immediate response to arguments made in a key Affordable Care Act constitutionality case, that Congress will reaffirm the law.

Sen. Cornyn Plans Bill To Secure US Genomic Research From Foreign 'Interference, Espionage And Exfiltration'

Threats from Chinese and other foreign researchers stealing US medical research and genomic intellectual property for their home countries’ gain continue, and in response, one Texas senator plans to introduce a Secure Our Research Act to protect federally funded research from foreign theft.

Biden Signs COVID-19 Relief EO To Expand And Accelerate Testing, Fill PPE Shortages

Under an extensive COVID-19 plan and executive order signed on 21 January, the US president explained how he’ll beef up testing and manufacturing of medtech to fight the virus.

Topics

UsernamePublicRestriction

Register

LL043624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel